Skip to main content

Rejected Lancet Correspondence: Workplace health promotion in India

The following rejected correspondence was written in respond to the editorial published in the Lancet Public Health

Title: Workplace health promotion in India

Vivek Podder; Tetsuya Tanimoto


The Lancet editorial (November 18, p 508)1 highlighted high-quality public health research for effective, low-cost interventions for workplace-related health. However, it may not work for people with poor health literacy and low socioeconomic conditions, especially in non-western countries. 

For example, as a middle-income nation, India is passing through a rapid economic growth, but health promotion is often neglected at workplace. As per a report from Indian study, over 55% of private employees in India do not perform any exercise and 68% of women are afflicted with different occupational lifestyle diseases.2 In India, increasing number of chronic diseases, which the World Health Organization has attributed to physical inactivity as a key risk factor, can bring economic loss of over $235 billion.3 

Therefore, it is warranted to take cultural contest into account; in case of India, Yoga would be a cost-effective and potentially effective intervention for counterproductive work behavior and preventing chronic diseases, although there is a paucity of high-quality evidence on long-term Yoga benefits being conducted at workplace. 

A growing body of evidence suggests Yoga practices, an ancient Indian discipline originating 4000 years ago, can reduce risk of cardiovascular diseases, improving physical health and wellbeing in a range of population and may benefit several workplace wellness needs of both employees and employers who are overweight, or with restricted joint mobility, are unable to participate in the conventional physical exercise at a low-cost.4,5 This would be well-suited for lower socioeconomic groups which may transform occupational health at the workplace. 


1. The LP. Public health and the workplace: a new era dawns. The Lancet Public health 2018; 3(11): 508. 
2. Officechai. 45% Of Young Indian Professionals Suffer From From Lifestyle Disorders. https://officechai.com/news/45-of-young-indian-professionals-suffer-lifestyle-disorders/ Date: 2016; Date accessed: November 29, 2018. 
3. Kirsten W Promoting physical activity at the workplace: a global view. Br J Sports Med. 2010; 44: 73-74. 
4. Hartfiel N, Havenhand J, Khalsa SB, Clarke G, Krayer A. The effectiveness of yoga for the improvement of well-being and resilience to stress in the workplace. Scand J Work Environ Health 2011; 1:70-6. 
5. TIME. Yoga Is Officially Sweeping the Workplace. http://time.com/4624276/yoga-workplacemindfulness/ Date: 2017; Date accessed: November 30, 2019. 

Comments

Popular posts from this blog

55 years Old male with Bipolar affected disorder moving from depression to Manic to depression phase

Disclaimer:- This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here December 2017 after collecting informed patient consent (form downloadable Click Here) This is a case of a 55 years old, diabetic, hypertensive patient who was diagnosed with Bipolar affected disorder since 1995. In 1995 due to financial loss he was attacked by this condition. He was seen by Dr. D. K Agarwala and diagnosed as BPAD-Depression phase and treated with lithium, sodium valporate, propranolol, Zeptol cr, Nitrosum - S.  With the treatment he was reasonably well but every 6 months of interval he appeared to have some disturbance like didn't want to talk to anybody, forgot to smile etc. They went to the doctor and treated accordingly and was continuing the treatment.  In the year of 2013, August he was diagnosed with BPAD-severe depression phase but, he was not responding well to the medications and then they went to NIMHANS for

Consent Forms

Hindi BMJ Consent form   Bengali BMJ Consent form English BMJ Consent form   Telegu BMJ Consent Form Telegu BMJ Consent Form   UDHC Consent Form                

drugs to avoid or use in terms of their pregnancy category

The optimal AEDs therapy of women with epilepsy who are of childbearing age is unclear because of a lack of conclusive data on the comparative teratogenicity of different antiseizure drugs and no antiepileptic drug has proven safe in pregnancy in terms of teratogenesis. Data on the comparative efficacy of various antiseizure drugs for controlling seizures during pregnancy are also quite limited, and there are no randomized trials in this setting. Treatment must be individualized for all patients. Women with epilepsy are classified as high risk during pregnancy and as there are no clear data indicating that any drug is without risk in pregnancy therefore, the antiseizure drug regimen should be optimized six months prior to planned conception.  Choice of antiepileptic drugs in women of childbearing age and  pregnant women with epilepsy:  1. T he antiseizure drug that stops seizures in a given patient is the one that should be used with an exception of valproate. 2.